Blood clot risk lower for estrogen-only, transdermal, and vaginal estrogen at menopause

A Swedish population study is helping answer lingering questions about hormone therapy safety. Published online today in Menopause, the journal of the North American Menopause Society, the study shows that estrogen-only therapy carries a lower risk of blood clots than combined estrogen-progestogen therapy, but there is no significantly increased risk of clots with combination therapy when the estrogen is transdermal, and vaginal estrogen doesn’t raise the risk at all. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail